Full Text View
Tabular View
No Study Results Posted
Related Studies
Peroral Levosimendan in Chronic Heart Failure
This study has been completed.
Study NCT00130884.   Last updated on February 19, 2007.
Information provided by Orion Corporation, Orion Pharma
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Heart Failure
Heart Diseases
Additional conditions recognized in this trial
Heart Failure
More general conditions related to this trial
Cardiovascular Diseases
Interventions listed in this trial
levosimendan
Additional drug interventions recognized in this trial
Simendan
More general drug interventions related to this trial
Anti-Arrhythmia Agents
Cardiotonic Agents
Cardiovascular Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Phosphodiesterase Inhibitors
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Orion Corporation, Orion Pharma


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services